[go: up one dir, main page]

AR109154A1 - TREATMENT AND PREVENTION OF SLEEP DISORDERS, PHARMACEUTICAL COMPOSITION, COMPOUND - Google Patents

TREATMENT AND PREVENTION OF SLEEP DISORDERS, PHARMACEUTICAL COMPOSITION, COMPOUND

Info

Publication number
AR109154A1
AR109154A1 ARP170102092A ARP170102092A AR109154A1 AR 109154 A1 AR109154 A1 AR 109154A1 AR P170102092 A ARP170102092 A AR P170102092A AR P170102092 A ARP170102092 A AR P170102092A AR 109154 A1 AR109154 A1 AR 109154A1
Authority
AR
Argentina
Prior art keywords
compound
prevention
treatment
pharmaceutical composition
sleep disorders
Prior art date
Application number
ARP170102092A
Other languages
Spanish (es)
Inventor
Garth Whiteside
Donald J Kyle
Ram P Kapil
Stephen C Harris
Original Assignee
Purdue Pharma Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Purdue Pharma Lp filed Critical Purdue Pharma Lp
Publication of AR109154A1 publication Critical patent/AR109154A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Métodos para tratar o prevenir un trastorno del sueño mediante la administración de un compuesto de la fórmula (1) a un animal que lo necesita.Methods for treating or preventing a sleep disorder by administering a compound of the formula (1) to an animal that needs it.

ARP170102092A 2016-07-26 2017-07-25 TREATMENT AND PREVENTION OF SLEEP DISORDERS, PHARMACEUTICAL COMPOSITION, COMPOUND AR109154A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662366960P 2016-07-26 2016-07-26

Publications (1)

Publication Number Publication Date
AR109154A1 true AR109154A1 (en) 2018-10-31

Family

ID=63963867

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170102092A AR109154A1 (en) 2016-07-26 2017-07-25 TREATMENT AND PREVENTION OF SLEEP DISORDERS, PHARMACEUTICAL COMPOSITION, COMPOUND

Country Status (1)

Country Link
AR (1) AR109154A1 (en)

Similar Documents

Publication Publication Date Title
MX388469B (en) TREATMENT AND PREVENTION OF SLEEP DISORDERS.
MX391850B (en) COMPOUNDS FOR USE IN THE TREATMENT OR AMENDING OF HUNTINGTON'S DISEASE
MX381069B (en) Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease
EA201891203A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
BR112017003658A2 (en) compound, mixture, methods for treating a disease and for inhibiting a glycosidase; and, pharmaceutical composition.
MX380866B (en) COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF COMPLEMENT FACTOR B.
MX2018006674A (en) CANCER TREATMENT USING 2-DESOXI-2-FLUORO-L-FUCOSA IN COMBINATION WITH A CONTROL POINT INHIBITOR.
MX2019000980A (en) Compounds and compositions and uses thereof.
BR112015026297A2 (en) combination therapy consisting of a tor kinase inhibitor and a substituted 5-quinazolinone compound for cancer treatment
MX390084B (en) P2X3 AND P2X2/3 DIAMINOPYRIMIDINE RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH.
EA201891377A1 (en) APPLICATION OF KV3.1 / Kv3.2 / Kv3.3 CHANNEL MODULATORS FOR PAIN TREATMENT
MX2016001446A (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof.
MX382175B (en) Monomethylfumarate prodrug compositions
MX2019010707A (en) METHODS TO TREAT AND / OR PREVENT ACTINIC KERATOSIS.
MX2019001634A (en) AMIDAS COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF THESE AND METHODS TO USE THEM.
MX2016015437A (en) COMBINATION THAT INCLUDES A GLUCOCORTICOID AND EDO-S101.
MX2018014080A (en) USE OF CARBAMATE COMPOUND TO PREVENT OR TREAT FIBROMIALGIA OR FUNCTIONAL SYNDROME ASSOCIATED WITH FIBROMIALGIA.
EA201891439A1 (en) TRICYCLIC COMPOUNDS AND THEIR COMPOSITIONS AS A KINAZ INHIBITOR
MX375924B (en) HEAT SHOCK PROTEIN 70 (HSP70) MODULATORS AND METHODS FOR MANUFACTURING AND USING THE SAME.
CL2019001618A1 (en) Use of carbamate compounds for prevention, relief or treatment of bipolar disorder.
MX2015012455A (en) Method for the treatment of fatty liver disease.
BR112017021589A2 (en) Methods For Treating Cardiovascular Disorders
MX2019006941A (en) USE OF CARBAMATE COMPOUND TO PREVENT, RELIEVE OR TREAT TREATS OR TREMOR SYNDROME.
AR109154A1 (en) TREATMENT AND PREVENTION OF SLEEP DISORDERS, PHARMACEUTICAL COMPOSITION, COMPOUND
MX2017008526A (en) 3,5-DIAMINOPIRAZOL QUINASA INHIBITORS.

Legal Events

Date Code Title Description
FC Refusal